Statement Of Cash Flows [Abstract]

Bayer AG - Filing #6464694

Concept 2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Increase (decrease) in working capital
19,000,000 EUR
4,223,000 EUR
Adjustments for increase (decrease) in employee benefit liabilities
494,000,000 EUR
183,000,000 EUR
Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) recognised in profit or loss
8,783,000 EUR
10,020,000 EUR
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets
2,778,000 EUR
2,751,000 EUR
Proceeds from disposals of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets
295,000,000 EUR
215,000,000 EUR
Cash flows from (used in) decrease (increase) in short-term deposits and investments
2,558,000 EUR
113,000,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.